Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma: final analysis of a randomized phase III dermatologic cooperative oncology group trial

Saved in:
Bibliographic Details
Main Authors: Mohr, Peter (Author) , Enk, Alexander (Author)
Format: Article (Journal)
Language:English
Published: 26 October 2015
In: Journal of clinical oncology
Year: 2015, Volume: 33, Issue: 34, Pages: 4077-4084
ISSN:1527-7755
DOI:10.1200/JCO.2014.59.6932
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1200/JCO.2014.59.6932
Get full text
Author Notes:Peter Mohr, Axel Hauschild, Uwe Trefzer, Alexander Enk, Wolfgang Tilgen, Carmen Loquai, Helen Gogas, Thomas Haalck, Josef Koller, Reinhard Dummer, Ralf Gutzmer, Norbert Brockmeyer, Erhard Hölzle, Cord Sunderkötter, Cornelia Mauch, Annette Stein, Lars A. Schneider, Maurizio Podda, Daniela Göppner, Dirk Schadendorf, and Michael Weichenthal
Description
Item Description:Gesehen am 28.07.2016
Physical Description:Online Resource
ISSN:1527-7755
DOI:10.1200/JCO.2014.59.6932